Independent Investors Inc Abbott Laboratories Transaction History

Independent Investors Inc

$490 Million
Q3 2024

A detailed history of Independent Investors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Independent Investors Inc holds 36,050 shares of ABT stock, worth $4.05 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

36,050

Previous 36,050 -0.0%

Holding current value

$4.05 Million

Previous $3.75 Million 9.75%

% of portfolio

0.84%

Previous 0.83%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$100.78 - $112.29 $808,054 - $900,341	-8,018 Reduced 18.19%	36,050 $3.93 Million
Q3 2022 Oct 24, 2022	BUY	$96.76 - $112.03 $1,741 - $2,016	18 Added 0.04%	44,068 $4.26 Million
Q3 2021 Oct 28, 2021	SELL	$116.66 - $129.06 $99,161 - $109,701	-850 Reduced 1.89%	44,050 $5.2 Million
Q4 2020 Jan 27, 2021	SELL	$105.0 - $114.42 $210,000 - $228,840	-2,000 Reduced 4.26%	44,900 $4.92 Million
Q2 2020 Jul 09, 2020	SELL	$76.57 - $98.0 $114,854 - $147,000	-1,500 Reduced 3.1%	46,900 $4.29 Million
Q1 2020 Apr 06, 2020	SELL	$62.82 - $91.86 $84,807 - $124,011	-1,350 Reduced 2.71%	48,400 $3.82 Million
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $47,106 - $52,440	-600 Reduced 1.19%	49,750 $4.32 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $158,928 - $192,144	-2,400 Reduced 4.55%	50,350 $4.02 Million
Q4 2018 Jan 14, 2019	BUY	$65.56 - $74.27 $13,112 - $14,854	200 Added 0.38%	52,750 $3.82 Million
Q3 2017 Oct 24, 2017	BUY	$48.06 - $53.64 $2.53 Million - $2.82 Million	52,550	52,550 $2.8 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Investors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Independent Investors Inc with notifications on news.

Account

Independent Investors Inc Abbott Laboratories Transaction History